Predictive and presymptomatic testing market to reach $9.31 billion by 2030 at 10.0% cagr, driven by rising prevalence of genetic disorders.
Read MoreThe Cell Therapy Technologies market size is expected to reach $11.35 billion in 2030 at a CAGR of 14.8%, driven by commercialization of cell therapies
Read MorePrecocious Puberty Treatment market size is expected to reach $2.56 billion by 2030 at 6.7%, driven by rising prevalence of hormonal disorders.
Read MoreGlobal Preclinical Imaging market size is expected to reach $5.18 billion by 2030 at 7.1%, rising chronic disease burden fuels preclinical imaging market growth
Read MoreThe Cell Therapy Processing Market is expected to reach $9.93 billion in 2030 at a CAGR of 13.8%, driven by commercialization of gene
Read MorePreclinical cro market to reach $9.83 billion by 2030 at 9.5% cagr, driven by increasing demand for preclinical trials.
Read MoreGlobal Preclinical Assets market size is expected to reach $10.2 billion by 2030 at 9.8%, increasing drug discovery
Read MoreGlobal Cell Signaling market size is expected to reach $7.11 billion by 2030 at 7.3%, segmented as by consumables, reagents, antibodies, kits (elisa, western blotting, etc.)
Read MoreThe precision psychiatry market will reach $9.81 by 2030 at 14.4% CAGR, driven by growth in wearable biosensors, genetic testing, telepsychiatry, and personalized mental health tools.
Read MoreGlobal Cell Separation Technologies market size is expected to reach $22.2 billion by 2030 at 14.1%, segmented as by instruments, centrifuges, magnetic cell sorters, flow cytometers
Read More